PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
11.45%
Revenue growth at 50-75% of MU's 19.75%. Martin Whitman would worry about competitiveness or product relevance.
11.88%
Gross profit growth under 50% of MU's 53.11%. Michael Burry would be concerned about a severe competitive disadvantage.
20.05%
EBIT growth below 50% of MU's 88.03%. Michael Burry would suspect deeper competitive or cost structure issues.
20.81%
Operating income growth under 50% of MU's 88.03%. Michael Burry would be concerned about deeper cost or sales issues.
21.69%
Net income growth under 50% of MU's 84.23%. Michael Burry would suspect the firm is falling well behind a key competitor.
22.86%
EPS growth under 50% of MU's 83.95%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
22.33%
Diluted EPS growth under 50% of MU's 81.82%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.60%
Share reduction while MU is at 0.64%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.69%
Reduced diluted shares while MU is at 1.47%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.00%
Dividend growth of 0.00% while MU is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
87.79%
OCF growth 1.25-1.5x MU's 71.32%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
100.52%
FCF growth under 50% of MU's 390.52%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
61.16%
10Y revenue/share CAGR under 50% of MU's 199.43%. Michael Burry would suspect a lasting competitive disadvantage.
38.87%
5Y revenue/share CAGR under 50% of MU's 128.76%. Michael Burry would suspect a significant competitive gap or product weakness.
26.13%
3Y revenue/share CAGR at 50-75% of MU's 34.85%. Martin Whitman would question if the firm lags behind competitor innovations.
61.31%
10Y OCF/share CAGR under 50% of MU's 2076.03%. Michael Burry would worry about a persistent underperformance in cash creation.
63.85%
Below 50% of MU's 213.22%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
33.59%
3Y OCF/share CAGR at 50-75% of MU's 59.60%. Martin Whitman would suspect weaker recent execution or product competitiveness.
137.49%
Below 50% of MU's 609.55%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
87.46%
Below 50% of MU's 559.45%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
66.91%
3Y net income/share CAGR 50-75% of MU's 97.14%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
41.50%
10Y equity/share CAGR in line with MU's 42.73%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
10.21%
Below 50% of MU's 84.81%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
12.58%
Below 50% of MU's 56.95%. Michael Burry suspects a serious short-term disadvantage in building book value.
522.75%
Dividend/share CAGR of 522.75% while MU is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
191.83%
Dividend/share CAGR of 191.83% while MU is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
66.48%
3Y dividend/share CAGR of 66.48% while MU is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
7.28%
AR growth is negative/stable vs. MU's 20.96%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-2.00%
Inventory is declining while MU stands at 2.13%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.99%
Similar asset growth to MU's 2.82%. Walter Schloss finds parallel expansions or investment rates.
3.24%
BV/share growth of 3.24% while MU is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
No Data
No Data available this quarter, please select a different quarter.
-0.79%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-5.07%
We cut SG&A while MU invests at 9.09%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.